During a high-stakes and politically charged Senate confirmation hearing, Dr Heidi Overton, President Donald Trump’s nominee to lead the US…
Read More
FDA Public Hearing Examines the Future of Psychedelic Therapeutics and Balanced Regulatory Pathways
On September 14, the United States Food and Drug Administration (FDA) convened a landmark public hearing to address the evolving…
Read More
The US Food and Drug Administration Convenes Public Hearing Amidst Scrutiny of Commissioner’s National Priority Voucher Program
The US Food and Drug Administration (FDA) is set to convene a significant public hearing on June 12, 2026, a…
Read More
